Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

Articles published in
JAMA
    September 2017
  1. SLOMSKI A
    Low-Fat Diet Reduces Mortality After Breast Cancer.
    JAMA. 2017;318:1099.
    >> Share

  2. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    >> Share

  3. LIVINGSTON EH, Li HC
    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    >> Share

  4. MCNEIL M
    Menopausal Hormone Therapy: Understanding Long-term Risks and Benefits.
    JAMA. 2017;318:911-913.
    >> Share

    August 2017
  5. SLOMSKI A
    Olaparib Increased Survival in Metastatic Breast Cancer.
    JAMA. 2017;318:690.
    >> Share

    June 2017
  6. KUCHENBAECKER KB, Hopper JL, Barnes DR, Phillips KA, et al
    Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
    JAMA. 2017;317:2402-2416.
    >> Share

    April 2017
  7. HIMELSTEIN AL, Loprinzi CL, Shapiro CL
    Zoledronic Acid Dosing Interval for Metastatic Cancer-Reply.
    JAMA. 2017;317:1478.
    >> Share

    February 2017
  8. SACKEIM MG
    Eradicating a Genetic Mutation.
    JAMA. 2017;317:809.
    >> Share

  9. ALLEN D
    Moving the Needle on Recovery From Breast Cancer: The Healing Role of Postmastectomy Tattoos.
    JAMA. 2017;317:672-674.
    >> Share

  10. RUGO HS, Klein P, Melin SA, Hurvitz SA, et al
    Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    JAMA. 2017;317:606-614.
    >> Share

  11. NANGIA J, Wang T, Osborne C, Niravath P, et al
    Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
    JAMA. 2017;317:596-605.
    >> Share

  12. HERSHMAN DL
    Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come.
    JAMA. 2017;317:587-588.
    >> Share

  13. MUTH CC
    Chemotherapy and Hair Loss.
    JAMA. 2017;317:656.
    >> Share

  14. KURIAN AW, Griffith KA, Hamilton AS, Ward KC, et al
    Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .
    JAMA. 2017;317:531-534.
    >> Share

    January 2017
  15. BRAGG F, Holmes MV, Iona A, Guo Y, et al
    Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China.
    JAMA. 2017;317:280-289.
    >> Share

  16. HIMELSTEIN AL, Foster JC, Khatcheressian JL, Roberts JD, et al
    Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.
    JAMA. 2017;317:48-58.
    >> Share

    December 2016
  17. BURSTEIN HJ, Schrag D
    Biosimilar Therapy for ERBB2 (HER2)-Positive Breast Cancer: Close Enough?
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18979.
    >> Share

  18. RUGO HS, Barve A, Waller CF, Hernandez-Bronchud M, et al
    Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016 Dec 1. doi: 10.1001/jama.2016.18305.
    >> Share

    November 2016
  19. ABBASI J
    The Nurses' Health Study Takes Fresh Aim at Breast Cancer as It Heads Into Decade Five.
    JAMA. 2016 Nov 23. doi: 10.1001/jama.2016.15976.
    >> Share

  20. FOUKAKIS T, von Minckwitz G, Bengtsson NO, Brandberg Y, et al
    Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2016;316:1888-1896.
    >> Share

    October 2016
  21. SLOMSKI A
    Tumor Gene Testing May Help Guide Breast Cancer Treatment Decisions.
    JAMA. 2016;316:1637.
    >> Share

  22. VAN DEN BELT-DUSEBOUT AW, van Leeuwen FE, Burger CW
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization-Reply.
    JAMA. 2016;316:1713-1714.
    >> Share

  23. TOMAO F, Papa A, Tomao S
    Breast Cancer Risk After Ovarian Stimulation for In Vitro Fertilization.
    JAMA. 2016;316:1713.
    >> Share

    July 2016
  24. VAN DEN BELT-DUSEBOUT AW, Spaan M, Lambalk CB, Kortman M, et al
    Ovarian Stimulation for In Vitro Fertilization and Long-term Risk of Breast Cancer.
    JAMA. 2016;316:300-12.
    >> Share

    May 2016
  25. CORLEY DA, Haas JS, Kobrin S
    Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium.
    JAMA. 2016;315:2067-8.
    >> Share

  26. TAYLOR-PHILLIPS S, Wallis MG, Jenkinson D, Adekanmbi V, et al
    Effect of Using the Same vs Different Order for Second Readings of Screening Mammograms on Rates of Breast Cancer Detection: A Randomized Clinical Trial.
    JAMA. 2016;315:1956-65.
    >> Share

  27. BURNSIDE ES, Sickles EA, Duffy SW
    A Pragmatic Approach to Determine Components of Optimal Screening Mammography Practice.
    JAMA. 2016;315:1951-3.
    >> Share

    April 2016
  28. KRESSIN NR, Gunn CM, Battaglia TA
    Content, Readability, and Understandability of Dense Breast Notifications by State.
    JAMA. 2016;315:1786-8.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016